Technology breakthroughs to break through industrial pain points and activate new dynamics in the biopharmaceutical industry.

In 2026, the year marks the beginning of the "14th Five-Year Plan", and the construction of "Healthy China" has entered a new stage of improving quality under the national strategic deployment. At present, China's pharmaceutical industry is in a period of structural adjustment and transformation, aiming to leap from a pharmaceutical power to an industry consensus. Around topics such as improving the innovative drug payment system and strengthening original innovation and industrial transformation, many national representatives and members of the Two Sessions have stated that the biopharmaceutical industry is an important field for nurturing new productive forces. It must focus on scientific and technological innovation as the core and new productive forces as the focus, based on the effectiveness and pain points of industrial development, break through development bottlenecks, strengthen the support of the entire chain, promote comprehensive upgrading of the industrial system through scientific and technological empowerment, and inject strong momentum into the construction of healthy China.